{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:42:31Z","timestamp":1772152951888,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07116-3","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:14:14Z","timestamp":1742310854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of povidone-iodine 10% plus levofloxacin 0.5% before cataract surgery: a randomized clinical trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Ali","family":"Azimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Namvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin","family":"Masihpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadi","family":"Meshksar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"7116_CR1","doi-asserted-by":"crossref","unstructured":"Fan C, Yang B, Huang Y. Efficacy of 0.5% levofloxacin and 5.0% povidone-iodine eyedrops in reducing conjunctival bacterial flora: metagenomic analysis. Journal of ophthalmology. 2020;2020.","DOI":"10.1155\/2020\/1780498"},{"key":"7116_CR2","doi-asserted-by":"crossref","unstructured":"Peyman A, Hosseini M, Narimani T. Comparison of the effects of povidone-iodine 5%, polyhexamethylene biguanide, and chlorhexidine as a preoperative antiseptic in endophthalmitis prophylaxis in patients undergoing phacoemulsification cataract surgery. Adv Biomedical Res. 2020;9.","DOI":"10.4103\/abr.abr_155_19"},{"issue":"1","key":"7116_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/ICU.0000000000000817","volume":"33","author":"A Grzybowski","year":"2022","unstructured":"Grzybowski A, Shimada H, Nakashizuka H, Koerner J. Low-concentration povidone-iodine for the prevention of intraocular infections in ophthalmic surgery. Curr Opin Ophthalmol. 2022;33(1):28\u201334.","journal-title":"Curr Opin Ophthalmol"},{"key":"7116_CR4","first-page":"191","volume-title":"Prophylaxis and Treatment of Endophthalmitis","author":"A Grzybowski","year":"2021","unstructured":"Grzybowski A, Turczynowska M. Prophylaxis and Treatment of Endophthalmitis. Cataract Surgery: Springer; 2021. pp. 191\u20139."},{"issue":"1","key":"7116_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcrs.2014.04.040","volume":"41","author":"MM Nentwich","year":"2015","unstructured":"Nentwich MM, Ta CN, Kreutzer TC, Li B, Schwarzbach F, Yactayo-Miranda YM, et al. Incidence of postoperative endophthalmitis from 1990 to 2009 using povidone\u2013iodine but no intracameral antibiotics at a single academic institution. J Cataract Refractive Surg. 2015;41(1):58\u201366.","journal-title":"J Cataract Refractive Surg"},{"issue":"3","key":"7116_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jcrs.2017.01.007","volume":"43","author":"MR Silas","year":"2017","unstructured":"Silas MR, Schroeder RM, Thomson RB, Myers WG. Optimizing the antisepsis protocol: effectiveness of 3 povidone\u2013iodine 1.0% applications versus a single application of povidone\u2013iodine 5.0%. J Cataract Refractive Surg. 2017;43(3):400\u20134.","journal-title":"J Cataract Refractive Surg"},{"issue":"1","key":"7116_CR7","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1111\/aos.14168","volume":"98","author":"A Grzybowski","year":"2020","unstructured":"Grzybowski A, Kanclerz P, Lytvynchuk L. Methods for achieving low endophthalmitis rates in phacoemulsification cataract surgery. Acta Ophthalmol. 2020;98(1):e128.","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"7116_CR8","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1038\/s41591-022-01989-8","volume":"28","author":"S Hopewell","year":"2022","unstructured":"Hopewell S, Boutron I, Chan A-W, Collins GS, de Beyer JA, Hr\u00f3bjartsson A, et al. An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials. Nat Med. 2022;28(9):1740\u20133.","journal-title":"Nat Med"},{"issue":"1","key":"7116_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jcrs.2011.06.030","volume":"38","author":"H Hosseini","year":"2012","unstructured":"Hosseini H, Ashraf MJ, Saleh M, Nowroozzadeh MH, Nowroozizadeh B, Abtahi MB, et al. Effect of povidone\u2013iodine concentration and exposure time on bacteria isolated from endophthalmitis cases. J Cataract Refractive Surg. 2012;38(1):92\u20136.","journal-title":"J Cataract Refractive Surg"},{"issue":"1","key":"7116_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1089\/jop.2006.22.54","volume":"22","author":"P-C Wu","year":"2006","unstructured":"Wu P-C, Li M, Chang S-J, Teng M-C, Yow S-G, Shin S-J, et al. Risk of endophthalmitis after cataract surgery using different protocols for povidone\u2013iodine preoperative disinfection. J Ocular Pharmacol Ther. 2006;22(1):54\u201361.","journal-title":"J Ocular Pharmacol Ther"},{"issue":"12","key":"7116_CR11","doi-asserted-by":"publisher","first-page":"e0189206","DOI":"10.1371\/journal.pone.0189206","volume":"12","author":"LF Barroso","year":"2017","unstructured":"Barroso LF, Cazella SP, Nepomuceno AB, Toscano L, Castilho L\u00c2dS, Furlan EMR, et al. Comparative efficacy of two different topical povidone-iodine 5% regimens in reducing conjunctival bacterial flora: a randomized parallel double-masked clinical trial. PLoS ONE. 2017;12(12):e0189206.","journal-title":"PLoS ONE"},{"issue":"2","key":"7116_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/bjo.87.2.163","volume":"87","author":"A Ferguson","year":"2003","unstructured":"Ferguson A, Scott J, McGavigan J, Elton R, McLean J, Schmidt U, et al. Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study. Br J Ophthalmol. 2003;87(2):163\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"7116_CR13","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jcrs.2013.02.039","volume":"39","author":"B Li","year":"2013","unstructured":"Li B, Nentwich MM, Hoffmann LE, Haritoglou C, Kook D, Kampik A, et al. Comparison of the efficacy of povidone\u2013iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery. J Cataract Refractive Surg. 2013;39(7):994\u20131001.","journal-title":"J Cataract Refractive Surg"},{"issue":"4","key":"7116_CR14","first-page":"229","volume":"76","author":"CF MJ","year":"2001","unstructured":"MJ CF, Claramunt G, Paredes B. Efficacy of topical povidone-iodine applied the day before cataract surgery to reduce conjunctival flora. Arch De La Sociedad Esp De Oftalmologia. 2001;76(4):229\u201334.","journal-title":"Arch De La Sociedad Esp De Oftalmologia"},{"issue":"4","key":"7116_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1089\/jop.2008.0102","volume":"25","author":"L He","year":"2009","unstructured":"He L, Ta CN, Hu N, Sinnar S, Mi\u00f1o de Kaspar H. Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjunctival bacteria. J Ocul Pharmacol Ther. 2009;25(4):373\u20138.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"12","key":"7116_CR16","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.jcrs.2009.06.038","volume":"35","author":"O Halachmi-Eyal","year":"2009","unstructured":"Halachmi-Eyal O, Lang Y, Keness Y, Miron D. Preoperative topical moxifloxacin 0.5% and povidon-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac. J Cataract Refract Surg. 2009;35(12):2109\u201314.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"7116_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ajo.2007.08.031","volume":"145","author":"HM De Kaspar","year":"2008","unstructured":"De Kaspar HM, Kreutzer TC, Aguirre-Romo I, Ta CN, Dudichum J, Bayrhof M, et al. A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora. Am J Ophthalmol. 2008;145(1):136\u201342. e2.","journal-title":"Am J Ophthalmol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07116-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07116-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07116-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:14:17Z","timestamp":1742310857000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07116-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7116"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07116-3","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods and experimental protocols were under the tenets of the Declaration of Helsinki and approved by the ethics committee of Shiraz University of Medical Sciences and the Iranian Registry of Clinical Trials (IR.SUMS.MED.REC.1398.610 and IRCT20191023045211N1). Consent to participate was obtained from the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All participants were informed about the interventions, and written informed consents were obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was a randomized clinical trial that approved by Iranian Registry of Clinical Trials (IRCT20191023045211N1) on 30th March 2023.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial registration"}},{"value":"This study was supported by Shiraz University of Medical Sciences and the grant number is 18,707.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source of support"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}